EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition

Faria Athar, Sarah Gregory iD, Emma J Houston, Nicole M Templeman iD

The Journal of Clinical Endocrinology & Metabolism · 19.05.2026 · 111 (6) · e1544-e1553

DOI: 10.1210/clinem/dgaf699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 03.01.2026. Verfasst von Faria Athar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Victoria, Victoria, BC V8P 5C2, Canada. Hauptthemen laut MEDLINE: Insulin, Perimenopause, Hot Flashes, Vasomotor System. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canada Research Chair in Metabolic Determinants of Reproduction and Aging, Michael Smith Health Research BC Scholar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Metabolic health affects the menopausal transition. Metabolic characteristics like body mass index (BMI) affect vasomotor syndrome incidence, but the role of elevated insulin, an early marker of metabolic dysfunction, remains understudied.

Objective

This work aimed to determine whether midlife insulin levels are associated with vasomotor symptom incidence or reproductive hormone trajectories.

Methods

Longitudinal analyses of community-based data from the Study of Women's Health Across the Nation (SWAN) were conducted. We analyzed the 704 SWAN participants (of 3302) without oophorectomy or hysterectomy who had metabolic data for age 47 and did not take insulin/medications for hyperglycemia. Mean fasting insulin at age 47 was 10.117 µIU/mL (SD = 6.711), with 27.0 BMI (SD = 6.6); the mean age of the final menstrual period for these participants was 51.0 years (SD = 2.3). Main outcome measures included vasomotor symptom timings and durations, and trajectories of estradiol (E2), follicle-stimulating hormone (FSH), and testosterone (T) across the menopausal transition.

Results

Higher insulin at age 47 predicted younger onsets of hot flashes and night sweats, longer durations of hot flashes and cold sweats, and greater T rise. BMI associations with vasomotor symptoms paralleled those of insulin, but BMI appeared more closely linked to slower E2 decline and blunted FSH rise. In Cox proportional hazards models, elevated age-47 insulin was associated with increased likelihood of hot flashes; this remained statistically significant with BMI and glucose as covariates.

Conclusion

Perimenopausal fasting insulin and BMI show complementary but distinct associations with menopausal changes. Elevated insulin predicts earlier and prolonged vasomotor symptoms, and is associated with higher T.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinPerimenopauseHot FlashesVasomotor SystemMenopauseHumansFemaleMiddle AgedLongitudinal StudiesIncidenceFollicle Stimulating HormoneEstradiolTestosteroneBody Mass IndexAdult

Stichwörter der Autor:innen

Study of Women's Health Across the Nation (SWAN)androgenclimacterichot flasheshyperinsulinemiainsulin resistance

Substanzen

InsulinFollicle Stimulating HormoneEstradiolTestosterone

Autor:innen und Institutionen

  • Department of Biology, University of Victoria, Victoria, BC V8P 5C2, Canada.
  • Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh EH16 4SB, UK.
  • Scottish Brain Sciences, Edinburgh EH12 5PJ, UK.
  • School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.

ORCID-Profile: Sarah Gregory, Nicole M Templeman

Förderung

  • CIHR
  • Canada Research Chair in Metabolic Determinants of Reproduction and Aging
  • Michael Smith Health Research BC Scholar
  • NIH HHS
  • HHS
  • NIA NIH HHS
  • NINR NIH HHS
  • NIH Office of Research on Women's Health

Zitieren

APA

Athar, F., Gregory, S., Houston, E. J., & Templeman, N. M. (2026). Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition. The Journal of Clinical Endocrinology & Metabolism, 111(6), e1544-e1553. https://doi.org/10.1210/clinem/dgaf699

Vancouver

Athar F, Gregory S, Houston EJ, Templeman NM. Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition. The Journal of Clinical Endocrinology & Metabolism. 2026;111(6):e1544-e1553. doi:10.1210/clinem/dgaf699

BibTeX
@article{Athar2026,
  author = {Athar, Faria and Gregory, Sarah and Houston, Emma J and Templeman, Nicole M},
  title = {Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {6},
  pages = {e1544--e1553},
  doi = {10.1210/clinem/dgaf699}
}
Kostenlos starten →